Tylenol’s parent company will combine with the maker of Huggies in a $48.7 billion mega

Tylenol's parent company Kenvue is being acquired by Kimberly-Clark. (Photo Illustration by Justin Sullivan/Getty Images) Justin Sullivan/Getty Images New York —

Huggies maker Kimberly-Clark announced Monday it will buy Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a massive consumer products conglomerate.

The merger is the latest in a recent dealmaking explosion, signaling the Trump administration’s openness toward corporate acquisitions. But it also represents a gamble that one of Kenvue’s signature products will be able to withstand increased scrutiny.

The acquisition comes a few weeks after President Donald Trump made unfounded claims linking autism to Tylenol use during pregnancy, sending Kenvue’s stock sharply lower. The company has staunchly pus